The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccrol Gp Regulatory News (ACRL)

  • This share is currently suspended. It was suspended at a price of 38.80

Share Price Information for Accrol Gp (ACRL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 38.80
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: -38.80 (-100.00%)
Open: 38.80
High: 38.80
Low: 38.80
Prev. Close: 38.80
ACRL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Launch of ESG Report

28 Sep 2021 09:46

RNS Number : 2134N
Accrol Group Holdings PLC
28 September 2021
 

 

Reach

 

Accrol Group Holdings plc

("Accrol" or the "Group")

 

Launch of Environmental, Social and Governance Report

 

Accrol, the UK's leading independent tissue converter, is pleased to announce that it has today published its first Environmental, Social and Governance ("ESG") Report, which is available on the Group's website: https://www.accrol.co.uk/esg/  

 

The report sets out the Group's vision for ESG and how it intends to achieve its goals, using clear targets and KPIs and a reporting framework against which progress will be demonstrated.

 

Gareth Jenkins, Chief Executive Officer of Accrol, said:

 

"Accrol's vision is to be a carbon neutral business that improves the lives of its people and communities, while working in partnership with suppliers to deliver sustainable products to customers and consumers and consistent results to our investors.

 

In this, our first sustainability report, we have detailed the actions we are currently taking and how we expect these to benefit both our business and our stakeholders. It also outlines what we plan to do next. Our relentless approach to operational excellence in the business applies equally to ESG and we will use this framework to measure our progress and showcase our performance over time."

 

For further information, please contact:

 

 

 

Accrol Group Holdings plc

 

Dan Wright, Executive Chairman

Via Belvedere Communications

Gareth Jenkins, Chief Executive Officer

Richard Newman, Chief Financial Officer

 

 

 

Zeus Capital Limited (Nominated Adviser & Broker) 

 

Dan Bate / Jordan Warburton

Tel: +44 (0) 161 831 1512

Dominic King / John Goold

Tel: +44 (0) 203 829 5000

 

 

Liberum Capital Limited (Joint Broker)

Tel: +44 (0) 20 3100 2222

Clayton Bush / Edward Thomas

 

 

 

Belvedere Communications Limited

 

Cat Valentine

Tel: +44 (0) 7715 769 078

Keeley Clarke

Tel: +44 (0) 7967 816 525

 

accrolpr@belvederepr.com

 

Overview of Accrol

 

Accrol Group Holdings plc is a leading tissue converter and supplier of toilet tissues, kitchen rolls, facial tissues, and wet wipes to many of the UK's leading discounters and grocery retailers across the UK. Following the recent acquisitions of LTC in Leicester and JD in Flint, North Wales, the Group now operates from six manufacturing sites, including four in Lancashire, which generate revenues totalling c.16% of the £2.1bn UK retail tissue market.

 

For more information, please visit www.accrol.co.uk

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAPPUPCBUPGURR
Date   Source Headline
22nd May 20187:00 amRNSOpen Offer
22nd May 20187:00 amRNSTR1
15th May 20185:16 pmRNSPosting of Circular
15th May 20183:08 pmRNSProposed Placing to raise £8 million
3rd May 20187:00 amRNSHolding(s) in Company
1st May 20182:06 pmRNSSecond Price Monitoring Extn
1st May 20182:00 pmRNSPrice Monitoring Extension
1st May 20187:00 amRNSRevised Banking Arrangements & Operational Update
4th Apr 20185:06 pmRNSDirector Shareholding
29th Mar 20183:26 pmRNSTR1: Standard form
29th Mar 20187:00 amRNSTR-1: Standard form
27th Mar 20183:43 pmRNSStatement re Share Price Movement
26th Mar 20184:41 pmRNSSecond Price Monitoring Extn
26th Mar 20184:35 pmRNSPrice Monitoring Extension
21st Mar 201812:32 pmRNSHolding(s) in Company
19th Mar 20187:00 amRNSTrading Update
15th Feb 20185:55 pmRNSDirector/PDMR Shareholding
13th Feb 20187:00 amRNSDirector/PDMR Shareholding
8th Feb 20184:31 pmRNSDirector/PDMR Shareholding
5th Feb 20187:00 amRNSBoard Changes
23rd Jan 20181:16 pmRNSPDMR Dealings
22nd Jan 20187:01 amRNSInterim Results for six months ended 31 Oct 2017
22nd Jan 20187:00 amRNSBoard Change
17th Jan 20183:25 pmRNSUpdate on Health and Safety Incident
4th Jan 20187:00 amRNSTR-1: Standard form
3rd Jan 20187:00 amRNSNotice of Half Year Results
13th Dec 201710:57 amRNSHolding(s) in Company
12th Dec 20177:00 amRNSHolding(s) in Company
11th Dec 20178:02 amRNSDirectors' Dealings
11th Dec 20178:01 amRNSPlacing Shares Admitted
8th Dec 201711:09 amRNSResult of General Meeting
30th Nov 20177:00 amRNSReplacement - TR-1
29th Nov 20172:05 pmRNSTR-1: Standard form
21st Nov 20174:40 pmRNSSecond Price Monitoring Extn
21st Nov 20174:35 pmRNSPrice Monitoring Extension
21st Nov 20177:00 amRNSPosting of Circular
20th Nov 20177:30 amRNSRestoration - Accrol Group Holdings Plc
20th Nov 20177:00 amRNSProposed Placing of £18m and Lifting of Suspension
12th Oct 20174:05 pmRNSUpdate on Health and Safety incident
9th Oct 20177:00 amRNSUpdate on Suspension of Trading on AIM
5th Oct 20177:30 amRNSSuspension - Accrol Group Holdings Plc
5th Oct 20177:00 amRNSTrading Update and Temporary Suspension of Trading
22nd Sep 20172:47 pmRNSResult of AGM
19th Sep 20173:16 pmRNSHolding(s) in Company
7th Sep 20177:00 amRNSAppointment of Chief Executive and Trading Update
10th Aug 20177:00 amRNSPosting of Accounts & Notice of AGM (Replacement)
9th Aug 20177:00 amRNSPosting of Accounts & Notice of AGM - Date change
10th Jul 20177:01 amRNSAppointment of Joint Corporate Broker
10th Jul 20177:00 amRNSPreliminary results for year ended 30 April 2017
26th Jun 20179:06 amRNSInvestment in new manufacturing line for Leyland

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.